Australian shares are poised to end a 10-day winning streak, down 0.3% to 8003 points by midday, reflecting a negative Wall Street session where the Nasdaq dropped 1.7%. Investors are closely analyzing ASX earnings for market direction cues.

Portfolio manager Ben Clark of TMS Capital highlighted a focus on margins, noting that high-quality companies like WiseTech and Goodman Group have shown strong cost control, resulting in margin improvements. Conversely, cost-sensitive sectors like retail have produced mixed results.

In other developments, Elanor Investors’ shares are suspended as the fund manager seeks $6 billion to refinance debt. Telix Pharmaceuticals reported its first half-year profit, with shares up over 1300% in five years. Clarity Pharmaceuticals’ shares rose 3.3% to a record $7.12, while Fisher & Paykel upgraded its FY25 profit guidance, lifting shares by 8.3%. However, Accent Group and Inghams saw significant declines of 16% and 12.9%, respectively, after disappointing earnings reports.